Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: J Vasc Surg. 2019 Jul 26;71(3):854–861. doi: 10.1016/j.jvs.2019.05.035

Table III.

Predictors of approval of a prospective interventionist to enter patients in the stenting trial of the Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2)

Approved vs not approved, first review (N = 334) Approved vs not approved, second review (n = 160) Approved vs not approved, ever (n = 334)
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Subspeciality
 Cardiology 1.00 (reference) .15 1.00 (reference) .0009 1.00 (reference) .0001
 Radiology 0.32 (0.07–1.46) 0.38 (0.15–0.95) 0.87 (0.44–1.72)
 Neurology 0.22 (0.03–1.70) 0.66 (0.21–2.08) 0.45 (0.21–0.99)
 Neurosurgery 1.10 (0.43–2.87) 0.32 (0.11–0.91) 0.41 (0.21–0.80)
 Vascular surgery 0.38 (0.12–1.17) 0.12 (0.04–0.34) 0.26 (0.14–0.47)
Percentage of asymptomatic cases
 ≤50% 1.00 (reference) .85 1.00 (reference) .57 1.00 (reference) .67
 >50% 0.93 (0.43–2.00) 1.2 (0.64–2.25) 1.10 (0.71–1.70)
No. of 30 day stroke complications
 Zero 1.00 (reference) .23 1.00 (reference) 1.00 (reference) .69
 1 0.44 (0.15–1.31) 1.11 (0.54–2.31) .96 0.86 (0.51–1.43)
 2+ 0.35 (0.05–2.67) 1.06 (0.34–3.37) 0.74 (0.32–1.71)
Case rate (cases/year) 1.09 (1.06–1.13) <.0001 1.002 (0.97–1.03) .92 1.08 (1.05–1.11) <.0001

CI, Confidence interval; OR, odds ratio.